Eberhard Karls Universität Tübingen

Translational Highlights in Breast and Ovarian Cancer 2019 – Immunotherapy, DNA Repair, PI3K Inhibition and CDK4/6 Therapy (2019) Hartkopf AD, Mueller V, Woeckel A, Lux MP, Janni W, Ettl J, Belleville E, et al. Journal article, Review article A Supernova Remnant Counterpart for HESS J1832-085 (2019) Maxted NI, Filipović MD, Hurley-Walker N, Bojičić I, Rowell GP, Haberl F, Ruiter AJ, et al. Journal article Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node (2019) Leiter U, Stadler R, Mauch C, Hohenberger W, Brockmeyer NH, Sunderkötter C, Kaatz M, et al. Journal article Efficacy of Bifidobacterium longum, B. infantis and Lactobacillus acidophilus probiotics to prevent gut dysbiosis in preterm infants of 28+0-32+6 weeks of gestation: A randomised, placebo-controlled, double-blind, multicentre trial: The PRIMAL Clinical Study protocol (2019) Marissen J, Haiss A, Meyer C, Van Rossum T, Buente LM, Frommhold D, Gille C, et al. Journal article The 2017 Failed Outburst of GX 339-4: Relativistic X-Ray Reflection near the Black Hole Revealed by NuSTAR and Swift Spectroscopy (2019) Garcia JA, Tomsick JA, Sridhar N, Grinberg V, Connors RMT, Wang J, Steiner JF, et al. Journal article XMM-Newton and Fermi /LAT view on the supernova remnant 3C434.1 (2019) Doroshenko V, Malyshev D, Pühlhofer G, Dincel B, Sasaki M, Santangelo A Journal article Comparative Socioeconomic Study Of Patients In Germany With Dravet Syndrome, Refractory Epilepsy Or Epilepsy In Seizure Remission, And Their Caregivers (2019) Strzelczyk A, Schubert-Bast S, Bast T, Bettendorf U, Hamer H, Herting A, Kalski M, et al. Conference contribution ARIA guideline 2019: treatment of allergic rhinitis in the German health system (2019) Klimek L, Bachert C, Pfaar O, Becker S, Bieber T, Brehler R, Buhl R, et al. Journal article Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group (2019) Fuchs M, Goergen H, Kobe C, Kuhnert G, Lohri A, Greil R, Sasse S, et al. Journal article Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108) (2019) Klinghammer K, Gauler T, Dietz A, Grünwald V, Stöhlmacher J, Knipping S, Schroeder M, et al. Journal article